Meta-analysis of proton pump inhibitor use and the risk of developing gastric cancer or colorectal cancer Liu, Ke; Wang, Yong-Hong; Wang, Jun; More Liu, Ke; Wang, Yong-Hong; Wang, Jun; Chen, Bing; Luo, Na; Gong, Juan Less Anti-Cancer Drugs. 34(9):971-978, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges Zhao, Lu; Zhang, Jing; Wang, Na; More Zhao, Lu; Zhang, Jing; Wang, Na; Zhang, Dou; Wang, Ziwei; Yu, Yongchao; Mei, Qingyun; Liao, Dongying; Jia, Yingjie; Kong, Fanming Less Anti-Cancer Drugs. 34(9):979-984, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis Wang, Guangxin; Gao, Xia; Sun, Zhijun; More Wang, Guangxin; Gao, Xia; Sun, Zhijun; He, Tianyou; Huang, Chaogang; Li, Shouwei; Long, Haocheng Less Anti-Cancer Drugs. 34(9):1002-1009, October 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Single-step assembly of lipid-gelatin-epigallocatechin-3-gallate hybrid nanoparticles for cancer therapy Song, Juan; Yu, Xudong; Lv, Chengzhi; More Song, Juan; Yu, Xudong; Lv, Chengzhi; Wang, Dong Less Anti-Cancer Drugs. 34(9):1010-1017, October 2023. Abstract Abstract Favorite PDF Permissions Buy
Selpercatinib monotherapy in a Chinese patient with RET fusion/EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report Wu, Lin; Cheng, Ying; Huang, Dingzhi; More Wu, Lin; Cheng, Ying; Huang, Dingzhi; Sun, Yuping; Zhou, Chengzhi; Zhou, Jianying; Guo, Ye; Shao, Jingxin; Zhang, Wanli; Lu, Shun Less Anti-Cancer Drugs. 34(9):1058-1064, October 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
